Andlauer Healthcare Group (AND) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue rose 2.6% year-over-year to $161.4 million, driven by organic growth in Canadian specialized transportation and recovery in logistics, distribution, and packaging.
Canadian specialized transportation network delivered strong organic growth, with all product lines posting year-over-year revenue increases in Q2 2024.
Healthcare logistics segment returned to growth in both logistics/distribution and packaging product lines.
U.S. truckload business faced continued revenue and margin declines due to persistent post-pandemic rate pressures, resulting in the lowest margins since market entry.
Strong cash generation and low debt enabled significant share buybacks, including a $90 million substantial issuer bid and ongoing normal course issuer bid.
Financial highlights
Healthcare logistics segment revenue was $44.2 million, up 1.3% year-over-year, with 13% growth in packaging revenue.
Specialized transportation segment revenue reached $117.2 million, a 3.1% increase year-over-year, driven by Canadian organic growth and partially offset by U.S. truckload decline.
Ground transportation revenue was $105 million, up 1.5% year-over-year; air freight forwarding revenue was $7.9 million, up 3.1%.
Operating income was $22.2 million, down 1.9% year-over-year, mainly due to lower U.S. truckload contributions and higher SG&A expenses.
Net income was $15.7 million ($0.38 per diluted share), flat versus Q2 2023; total comprehensive income increased 69.2% to $18.1 million due to positive foreign currency translation.
EBITDA totaled $40.1 million, up 1.4% year-over-year; EBITDA margin was 24.8%, slightly down from 25.1% last year.
Outlook and guidance
Management expects to leverage its platform and core competencies to drive shareholder value, supported by positive long-term industry growth fundamentals in healthcare, transportation, and logistics.
Focus remains on improving U.S. truckload operations and pursuing disciplined financial and operational metrics.
Management remains focused on revenue quality, especially in the U.S. truckload segment, and continues to evaluate complementary acquisitions.
Latest events from Andlauer Healthcare Group
- Revenue up 3.1%, net income jumps 35.6%, and a $2.2B UPS acquisition announced.AND
Q1 202510 Mar 2026 - Record EBITDA margin and strong Canadian growth offset U.S. headwinds; outlook remains positive.AND
Q3 202416 Jan 2026 - Canadian growth and packaging gains offset U.S. truckload declines; stable margins, active buybacks.AND
Q4 202423 Dec 2025 - Revenue and net income declined as US truckload and transaction costs weighed, with UPS deal pending.AND
Q2 202518 Aug 2025